Publications
Export 15 results:
Filters: Keyword is Disease Progression [Clear All Filters]
“Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years.”, JAMA Netw Open, vol. 3, no. 11, p. e2018782, 2020.
, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.
, “The natural history of insomnia: acute insomnia and first-onset depression.”, Sleep, vol. 37, no. 1, pp. 97-106, 2014.
, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.
, “[Non-pharmacological therapies of language deficits in semantic dementia].”, Geriatr Psychol Neuropsychiatr Vieil, vol. 10, no. 4, pp. 427-36, 2012.
, “Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.”, J Neurochem, vol. 113, no. 5, pp. 1188-99, 2010.
, “Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.”, Neurobiol Dis, vol. 40, no. 1, pp. 245-50, 2010.
, “The natural history of insomnia: a population-based 3-year longitudinal study.”, Arch Intern Med, vol. 169, no. 5, pp. 447-53, 2009.
, “Psychological distress and risk for dementia.”, Curr Psychiatry Rep, vol. 11, no. 1, pp. 41-7, 2009.
, “Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.”, J Neurosci, vol. 28, no. 41, pp. 10234-44, 2008.
, “Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.”, Neurobiol Dis, vol. 26, no. 1, pp. 146-52, 2007.
, “Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.”, J Neurosci, vol. 24, no. 6, pp. 1340-9, 2004.
, “Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.”, J Neurosci, vol. 23, no. 6, pp. 2131-40, 2003.
, “Developmental changes of autistic symptoms.”, Autism, vol. 7, no. 3, pp. 255-68, 2003.
, “Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.”, Neurobiol Dis, vol. 10, no. 3, pp. 268-78, 2002.
,